Also found in: Medical, Wikipedia.


An angiotensin II receptor blocker drug, C25H28 N6O, used to treat hypertension.

[irbe-, origin unknown + -sartan, angiotensin II receptor blocker suff.; see losartan.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.


n irbesartán m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.
The ACTIVE (Atrial Fibrillation Clopidogrel Trial with Irbesartan for the Prevention of Vascular Events) trial of 7,554 patients with atrial fibrillation in 30 countries found clopidogrel added to Aspirin significantly reduced the risk of cardiovascular events, and particularly stroke.
His hypertension was treated with Norvasc, Clonidine, Irbesartan, and Metoprolol.
Two simple and accurate spectrophotometric methods were presented for the determination of binary mixtures of each of Eprosartan and Irbesartan with Hydrochlorothiazide in dosage forms.
Under the agreement terms, BMKK will sublicense to DSP the development, manufacturing/marketing and marketing rights of irbesartan, an anti-hypertension drug.
(7.) Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P; Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group.
He was prescribed irbesartan tablets by his GP for the condition.
(11) Angiotensin II Losartan (Cozaar), valsartan Works by blocking receptor (Diovan), irbesartan (Avapro), angiotensin II blockers and candesartan (Atacand) receptors on cells, helping reduce blood pressure.
Bristol-Myers Squib and Sanofi-Synthelabo report the FDA approval was based on results from an Irbesartan Diabetic Nephropathy Trial which demonstrated that when patients with high blood pressure, type 2 diabetes and evidence of kidney disease were treated with Avapro the risk of progression of their nephropathy or death was 20% lower than that of the placebo group and 23% lower than the group treated with amlodipine, a calcium-channel blocker.
The other two studies examined another blood pressure drug, irbesartan, which also blocks angiotensin receptors.
Now available in the United States, Avalide combines Bristol-Myers Squibb's and Sanofi's Avapro (irbesartan) and hydrochlorothiazide.